User profiles for Andrea Zhou
Andrea ZhouiTHRIV, University of Virginia Verified email at virginia.edu Cited by 119 |
[HTML][HTML] Long COVID risk and pre-COVID vaccination in an EHR-based cohort study from the RECOVER program
Long COVID, or complications arising from COVID-19 weeks after infection, has become a
central concern for public health experts. The United States National Institutes of Health …
central concern for public health experts. The United States National Institutes of Health …
A first-in-class polymerase theta inhibitor selectively targets homologous-recombination-deficient tumors
DNA polymerase theta (POLθ or POLQ) is synthetic lethal with homologous recombination (HR)
deficiency and is thus a candidate target for HR-deficient cancers. Through high-…
deficiency and is thus a candidate target for HR-deficient cancers. Through high-…
The complete genome sequence of the hyperthermophilic, sulphate-reducing archaeon Archaeoglobus fulgidus
…, BP Kaine, SM Sykes, PW Sadow, KP D'Andrea… - Nature, 1997 - nature.com
Archaeoglobus fulgidus is the first sulphur-metabolizing organism to have its genome sequence
determined. Its genome of 2,178,400 base pairs contains 2,436 open reading frames (…
determined. Its genome of 2,178,400 base pairs contains 2,436 open reading frames (…
[HTML][HTML] An expanded evaluation of protein function prediction methods shows an improvement in accuracy
Background A major bottleneck in our understanding of the molecular underpinnings of life
is the assignment of function to proteins. While molecular experiments provide the most …
is the assignment of function to proteins. While molecular experiments provide the most …
Human cardiomyocytes express high level of Na+/glucose cotransporter 1 (SGLT1)
L Zhou, EV Cryan, MR D'Andrea… - Journal of cellular …, 2003 - Wiley Online Library
We have quantitatively measured gene expression for the sodium‐dependent glucose
cotransporters 1 and 2 (SGLT1 and SGLT2) in 23 human tissues using the method of real time …
cotransporters 1 and 2 (SGLT1 and SGLT2) in 23 human tissues using the method of real time …
[HTML][HTML] Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer
…, PK Sorger, EM Swisher, AD D'Andrea… - Nature …, 2020 - nature.com
Combined PARP and immune checkpoint inhibition has yielded encouraging results in
ovarian cancer, but predictive biomarkers are lacking. We performed immunogenomic profiling …
ovarian cancer, but predictive biomarkers are lacking. We performed immunogenomic profiling …
Genomic subtyping and therapeutic targeting of acute erythroleukemia
Acute erythroid leukemia (AEL) is a high-risk leukemia of poorly understood genetic basis,
with controversy regarding diagnosis in the spectrum of myelodysplasia and myeloid leukemia…
with controversy regarding diagnosis in the spectrum of myelodysplasia and myeloid leukemia…
[HTML][HTML] Structural basis of Rev1-mediated assembly of a quaternary vertebrate translesion polymerase complex consisting of Rev1, heterodimeric polymerase (Pol) ζ …
DNA synthesis across lesions during genomic replication requires concerted actions of
specialized DNA polymerases in a potentially mutagenic process known as translesion synthesis…
specialized DNA polymerases in a potentially mutagenic process known as translesion synthesis…
Cooperation of the NEIL3 and Fanconi anemia/BRCA pathways in interstrand crosslink repair
…, SS Wallace, J Chen, J Zhou, AD D'Andrea - Nucleic Acids …, 2020 - academic.oup.com
The NEIL3 DNA glycosylase is a base excision repair enzyme that excises bulky base
lesions from DNA. Although NEIL3 has been shown to unhook interstrand crosslinks (ICL) in …
lesions from DNA. Although NEIL3 has been shown to unhook interstrand crosslinks (ICL) in …
[HTML][HTML] Minimally invasive surgery for gastric cancer: A comparison between robotic, laparoscopic and open surgery
…, S Zhang, G Palazzini, V D'andrea… - World journal of …, 2017 - ncbi.nlm.nih.gov
AIM To investigate the role of minimally invasive surgery for gastric cancer and determine
surgical, clinical, and oncological outcomes. METHODS This is a propensity score-matched …
surgical, clinical, and oncological outcomes. METHODS This is a propensity score-matched …